Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma.

Jun-Xi XiangXu-Feng ZhangSharon M WeberGeorge PoultsidesRyan C FieldsIoannis HatzarasMatthew WeissCharles ScogginsKamron IdreesPerry ShenShishir K MaithelTimothy M Pawlik

Published in: Journal of surgical oncology (2021)

While low-risk patients did not benefit from adjuvant chemotherapy, individuals with medium or high-risk scores had an improved survival with the utilization of adjuvant chemotherapy.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported